Full name : Toler Steven
First name : Steven
Mail : Department of Clinical Pharmaceutical Sciences, Targacept, Inc., Winston-Salem, NC 27101
Zip Code :
City :
Country : USA
Email : Steven.Toler@Targacept.com
Phone :
Fax :
Website :
Directory :
| Title : Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia - Walling_2016_Schizophr.Bull_42_335 |
| Author(s) : Walling D , Marder SR , Kane J , Fleischhacker WW , Keefe RS , Hosford DA , Dvergsten C , Segreti AC , Beaver JS , Toler SM , Jett JE , Dunbar GC |
| Ref : Schizophr Bull , 42 :335 , 2016 |
| Abstract : Walling_2016_Schizophr.Bull_42_335 |
| ESTHER : Walling_2016_Schizophr.Bull_42_335 |
| PubMedSearch : Walling_2016_Schizophr.Bull_42_335 |
| PubMedID: 26071208 |
| Title : Anticholinergic therapy for overactive bladder: a nicotinic modality? - Toler_2013_Med.Hypotheses_81_456 |
| Author(s) : Toler SM , Yohannes D , Lippiello PM , Chancellor MB |
| Ref : Med Hypotheses , 81 :456 , 2013 |
| Abstract : Toler_2013_Med.Hypotheses_81_456 |
| ESTHER : Toler_2013_Med.Hypotheses_81_456 |
| PubMedSearch : Toler_2013_Med.Hypotheses_81_456 |
| PubMedID: 23834857 |